Follow
Guard Therapeutics International AB
Nasdaq First North Sweden (Sweden)
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.
Sector:
HEALTH CARE
>
Biotechnology
Sector:
TECHNOLOGY
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
GUARD
SE0009973357
Nasdaq First North Sweden
Sweden (SE)
Details of share in Guard Therapeutics International AB with ticker GUARD
Status
Active
Order book id
Amount of instruments
154 124 156
Par value
0.4000
Market cap
Currency
SEK
Segment
First North
Terms
Type
Price
Pre-money valuation
Time
Files
Listing
03 Apr 2013
Direct listing of Guard Therapeutics International AB on Nasdaq First North Sweden
Market
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
The shares in A1M Pharma AB will start trading on AktieTorget on April 3, 2013.
Documents
Type
Price
Pre-money valuation
Time
Files
New issue
2.60 SEK
40M SEK
13 May - 27 May 2014
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
13 May - 27 May 2014
Subscription price
2.60 SEK
Price per share
2.60 SEK
Target to raise
23 980 000 SEK
Types
Share issue
Pre-money valuation
40 000 000 SEK
Subscription block size
Minimum subscription
Record date
09 May 2014
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 3:5. For each existing share one (1) subscription right is obtained. The holding of five (5) subscription rights entitles the holder to subscribe for three (3) new shares.
Comments for offer & related information
A1M Pharma has received subscription commitments of approximately SEK 9.3 million and a guarantee subscription of approximately SEK 11 million, totaling approximately 85 percent of the issue volume. At the same time as this rights issue, a set-off issue is also being implemented for a convertible loan of SEK 15 million previously received from A1M Pharma from the company's principal owner Baulos Capital Belgium SA.
Type
Price
Pre-money valuation
Time
Files
New issue
5.50 SEK
159.4M SEK
15 Apr - 29 Apr 2015
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
15 Apr - 29 Apr 2015
Subscription price
11.00 SEK
Price per share
5.50 SEK
Target to raise
29 000 000 SEK
Types
Share issue
Pre-money valuation
159 400 000 SEK
Subscription block size
Minimum subscription
Record date
10 Apr 2015
Offer status
Closed
Listing status
Listed
Issue terms
Preferential right 2:11. One (1) unit right is obtained for each existing share. Holding of eleven (11) unit rights entitles the holder to subscribe for one (1) unit. One (1) unit consists of two (2) new shares and one (1) free-of-charge warrants of series TO 1.
Comments for offer & related information
Subscription commitments and guarantee subscription: A1M Pharma has received subscription commitments of approximately SEK 17.4 million and a guarantee subscription (without compensation) of approximately SEK 8 million, corresponding to approximately 88 percent of the issue volume.
Holding of one (1) warrants of the TO 1 series entitles the holder to subscribe for one (1) newly issued share at a price of SEK 6.00. Subscription of shares with the support of warrants may take place from 5 November 2015 to 26 November 2015. This shall be done by simultaneous cash payment no later than 15.00 on 26 November 2015.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
05 Nov - 24 Nov 2015
Option exercise terms for A1M TO 1
Former company name
A1M Pharma AB
Market
Spotlight
Exercise period(s)
05 Nov - 24 Nov 2015
Exercise price
6.00 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Files
New issue
2.60 SEK
98.3M SEK
19 May - 02 Jun 2016
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
19 May - 02 Jun 2016
Subscription price
Price per share
2.60 SEK
Target to raise
43 700 000 SEK
Types
Share issue
Pre-money valuation
98 300 000 SEK
Subscription block size
Minimum subscription
Record date
13 May 2016
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:9. For each existing share one (1) subscription right is obtained. The holding of nine (9) subscription rights entitles the holder to subscribe for four (4) new shares.
Comments for offer & related information
In advance, A1M Pharma has agreed in writing on subscription commitments of approximately SEK 8.3 million and a guarantee subscription of approximately SEK 35.4 million, a total corresponding to the entire issue volume.
Type
Price
Pre-money valuation
Time
Files
New issue
0.75 SEK
41M SEK
24 Mar - 07 Apr 2017
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
24 Mar - 07 Apr 2017
Subscription price
2.25 SEK
Price per share
0.75 SEK
Target to raise
122 900 000 SEK
Types
Share issue
Pre-money valuation
41 000 000 SEK
Subscription block size
Minimum subscription
Record date
16 Mar 2017
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 3:1. One (1) unit right is obtained for each existing share. One (1) such unit right entitles the holder to subscribe for one (1) Unit consisting of three (3) new shares and one (1) warrant entitling to subscribe for one (1) new share in the company.
Comments for offer & related information
One (1) subscription option entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 0.75 per share in cash.
Subscription of shares in the company with the support of warrants can take place during the period 28 August 2017 to 8 September 2017 and the period 27 November 2017 to 8 December 2017.
Type
Price
Pre-money valuation
Time
Files
Market move
20 Jun 2017
Listing of Guard Therapeutics International AB on Nasdaq First North Sweden
Former ticker
A1M
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
A1M Pharma AB changed it’s listing from Aktietorget to Nasdaq First North Sweden. The first trading day for the instrument(s) on Nasdaq First North is the 20th of June 2017.
Documents
Type
Price
Pre-money valuation
Time
Files
Exercise
15.00 SEK
28 Aug - 08 Sep 2017
27 Nov - 08 Dec 2017
Option exercise terms for A1M TO 2
Former company name
A1M Pharma AB
Former ticker
A1M TO
Market
Nasdaq First North Sweden
Exercise period(s)
28 Aug - 08 Sep 2017
27 Nov - 08 Dec 2017
Exercise price
15.00 SEK
Status
Closed
Issue terms
Twenty (20) equity rights give the right to subcribe for one (1) new share in A1M Pharma AB.
Type
Price
Pre-money valuation
Time
Files
New issue
5.00 SEK
41.5M SEK
07 Mar - 21 Mar 2018
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Former ticker
A1M
Market
Nasdaq First North Sweden
Subscription period
07 Mar - 21 Mar 2018
Subscription price
5.00 SEK
Price per share
5.00 SEK
Target to raise
83 000 000 SEK
Types
Share issue
Pre-money valuation
41 500 000 SEK
Subscription block size
Minimum subscription
Record date
02 Mar 2018
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 2:1. For each existing share one (1) subscription right is obtained. Such a subscription right entitles the holder to subscribe for two (2) new shares in the company.
Comments for offer & related information
A1M Pharma has received subscription commitments from certain shareholders totaling SEK 4.3 million, corresponding to approximately 5.1 percent of the rights issue. Subscription commitments have been received, among other things, from certain shareholders (MSEK 2.2), all Board members and senior executives (MSEK 0.5) and Fredrik Olsson, who is a partner in the Company's largest shareholder Baulos Capital Belgium SA (MSEK 1.5).
In addition, through a guarantee commitment, a number of institutional and private investors have undertaken to subscribe for shares in the rights issue, which may not be subscribed with or without support of subscription rights, up to approximately SEK 62.2 million, corresponding to 75.0 percent of the rights issue.
At the same time, A1M Pharma has taken out a bridge loan of SEK 7.5 million. The bridge loan secures A1M Pharma's short-term financing, pending issuance of cash proceeds.
Type
Price
Pre-money valuation
Time
Files
New issue
0.85 SEK
17.5M SEK
06 Feb - 20 Feb 2019
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Former ticker
A1M
Market
Nasdaq First North Sweden
Subscription period
06 Feb - 20 Feb 2019
Subscription price
10.20 SEK
Price per share
0.85 SEK
Target to raise
70 539 000 SEK
Types
Share issue
Pre-money valuation
17 500 000 SEK
Subscription block size
Minimum subscription
Record date
31 Jan 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:1. Each existing share entitles one (1) unit right. Three (3) unit rights give the right to subscribe for one (1) unit. One (1) unit contains twelve (12) new shares and four (4) free warrants.
Comments for offer & related information
The rights issue is secured through subscription and guarantee commitments up to 100.0 percent of the total issue amount. The space between 56.0 percent up to 100.0 percent, corresponding to SEK 31.0 million of the Rights Issue consists of a so-called top guarantee with, among others, M2 Asset Management AB and John Fällström.
At the same time, A1M Pharma has raised a bridge loan of SEK 13.0 million. The bridge loan secures A1M Pharma's short-term financing, pending issuance of cash proceeds.
One (1) warrants entitle to subscribe for one (1) new share in the Company at a subscription price of SEK 1.00 during October 2019
Type
Price
Pre-money valuation
Time
Files
New issue
1.05 SEK
108.92M SEK
17 Jun 2019
Share issue in Guard Therapeutics International AB
Former ticker
A1M
Market
Nasdaq First North Sweden
Subscription date
17 Jun 2019
Subscription price
1.05 SEK
Price per share
1.05 SEK
Target to raise
27 230 226 SEK
Types
Share issue
Pre-money valuation
108 920 906 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed issue, subscribers comprise a number of Swedish institutional and private investors consisting of Jan Ståhlberg (SEK 10 million), M2 Asset Management (SEK 7.3 million), the Union (SEK 4.2 million), Axel Karlsson (SEK 2.6 million) , Galba Holding (SEK 2.0 million) and Tommy Ure (SEK 1.1 million).
Comments for offer & related information
The targeted share issue comprises 25,933,549 new shares.

Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
07 Oct - 25 Oct 2019
Option exercise terms for A1M TO 3
Former company name
A1M Pharma AB
Former ticker
A1M TO
Market
Nasdaq First North Sweden
Exercise period(s)
07 Oct - 25 Oct 2019
Exercise price
1.00 SEK
Status
Closed
Issue terms
One (1) warrant entitle to subscribe for one (1) new share.
Type
Ticker
ISIN
Market
SHARE
A1M
SE0005876828
Spotlight
Sweden (SE)
Details of share in Guard Therapeutics International AB with ticker A1M
Status
Archived
Order book id
93181
Amount of instruments
Par value
Market cap
Currency
SEK
Terms
Type
Price
Pre-money valuation
Time
Files
Listing
03 Apr 2013
Direct listing of Guard Therapeutics International AB on Nasdaq First North Sweden
Market
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
The shares in A1M Pharma AB will start trading on AktieTorget on April 3, 2013.
Documents
Type
Price
Pre-money valuation
Time
Files
New issue
2.60 SEK
40M SEK
13 May - 27 May 2014
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
13 May - 27 May 2014
Subscription price
2.60 SEK
Price per share
2.60 SEK
Target to raise
23 980 000 SEK
Types
Share issue
Pre-money valuation
40 000 000 SEK
Subscription block size
Minimum subscription
Record date
09 May 2014
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 3:5. For each existing share one (1) subscription right is obtained. The holding of five (5) subscription rights entitles the holder to subscribe for three (3) new shares.
Comments for offer & related information
A1M Pharma has received subscription commitments of approximately SEK 9.3 million and a guarantee subscription of approximately SEK 11 million, totaling approximately 85 percent of the issue volume. At the same time as this rights issue, a set-off issue is also being implemented for a convertible loan of SEK 15 million previously received from A1M Pharma from the company's principal owner Baulos Capital Belgium SA.
Type
Price
Pre-money valuation
Time
Files
New issue
5.50 SEK
159.4M SEK
15 Apr - 29 Apr 2015
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
15 Apr - 29 Apr 2015
Subscription price
11.00 SEK
Price per share
5.50 SEK
Target to raise
29 000 000 SEK
Types
Share issue
Pre-money valuation
159 400 000 SEK
Subscription block size
Minimum subscription
Record date
10 Apr 2015
Offer status
Closed
Listing status
Listed
Issue terms
Preferential right 2:11. One (1) unit right is obtained for each existing share. Holding of eleven (11) unit rights entitles the holder to subscribe for one (1) unit. One (1) unit consists of two (2) new shares and one (1) free-of-charge warrants of series TO 1.
Comments for offer & related information
Subscription commitments and guarantee subscription: A1M Pharma has received subscription commitments of approximately SEK 17.4 million and a guarantee subscription (without compensation) of approximately SEK 8 million, corresponding to approximately 88 percent of the issue volume.
Holding of one (1) warrants of the TO 1 series entitles the holder to subscribe for one (1) newly issued share at a price of SEK 6.00. Subscription of shares with the support of warrants may take place from 5 November 2015 to 26 November 2015. This shall be done by simultaneous cash payment no later than 15.00 on 26 November 2015.
Type
Price
Pre-money valuation
Time
Files
New issue
2.60 SEK
98.3M SEK
19 May - 02 Jun 2016
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
19 May - 02 Jun 2016
Subscription price
Price per share
2.60 SEK
Target to raise
43 700 000 SEK
Types
Share issue
Pre-money valuation
98 300 000 SEK
Subscription block size
Minimum subscription
Record date
13 May 2016
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:9. For each existing share one (1) subscription right is obtained. The holding of nine (9) subscription rights entitles the holder to subscribe for four (4) new shares.
Comments for offer & related information
In advance, A1M Pharma has agreed in writing on subscription commitments of approximately SEK 8.3 million and a guarantee subscription of approximately SEK 35.4 million, a total corresponding to the entire issue volume.
Type
Price
Pre-money valuation
Time
Files
New issue
0.75 SEK
41M SEK
24 Mar - 07 Apr 2017
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
24 Mar - 07 Apr 2017
Subscription price
2.25 SEK
Price per share
0.75 SEK
Target to raise
122 900 000 SEK
Types
Share issue
Pre-money valuation
41 000 000 SEK
Subscription block size
Minimum subscription
Record date
16 Mar 2017
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 3:1. One (1) unit right is obtained for each existing share. One (1) such unit right entitles the holder to subscribe for one (1) Unit consisting of three (3) new shares and one (1) warrant entitling to subscribe for one (1) new share in the company.
Comments for offer & related information
One (1) subscription option entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 0.75 per share in cash.
Subscription of shares in the company with the support of warrants can take place during the period 28 August 2017 to 8 September 2017 and the period 27 November 2017 to 8 December 2017.
Type
Ticker
ISIN
Market
SHARE
GUARD
SE0009973357
Nasdaq First North Sweden
Sweden (SE)
Details of share in Guard Therapeutics International AB with ticker GUARD
Status
Active
Order book id
Amount of instruments
154 124 156
Par value
0.4000
Market cap
Currency
SEK
Segment
First North
Terms
Type
Price
Pre-money valuation
Time
Files
Market move
20 Jun 2017
Listing of Guard Therapeutics International AB on Nasdaq First North Sweden
Former ticker
A1M
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
A1M Pharma AB changed it’s listing from Aktietorget to Nasdaq First North Sweden. The first trading day for the instrument(s) on Nasdaq First North is the 20th of June 2017.
Documents
Type
Price
Pre-money valuation
Time
Files
New issue
5.00 SEK
41.5M SEK
07 Mar - 21 Mar 2018
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Former ticker
A1M
Market
Nasdaq First North Sweden
Subscription period
07 Mar - 21 Mar 2018
Subscription price
5.00 SEK
Price per share
5.00 SEK
Target to raise
83 000 000 SEK
Types
Share issue
Pre-money valuation
41 500 000 SEK
Subscription block size
Minimum subscription
Record date
02 Mar 2018
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 2:1. For each existing share one (1) subscription right is obtained. Such a subscription right entitles the holder to subscribe for two (2) new shares in the company.
Comments for offer & related information
A1M Pharma has received subscription commitments from certain shareholders totaling SEK 4.3 million, corresponding to approximately 5.1 percent of the rights issue. Subscription commitments have been received, among other things, from certain shareholders (MSEK 2.2), all Board members and senior executives (MSEK 0.5) and Fredrik Olsson, who is a partner in the Company's largest shareholder Baulos Capital Belgium SA (MSEK 1.5).
In addition, through a guarantee commitment, a number of institutional and private investors have undertaken to subscribe for shares in the rights issue, which may not be subscribed with or without support of subscription rights, up to approximately SEK 62.2 million, corresponding to 75.0 percent of the rights issue.
At the same time, A1M Pharma has taken out a bridge loan of SEK 7.5 million. The bridge loan secures A1M Pharma's short-term financing, pending issuance of cash proceeds.
Type
Price
Pre-money valuation
Time
Files
New issue
0.85 SEK
17.5M SEK
06 Feb - 20 Feb 2019
Share issue in Guard Therapeutics International AB
Former company name
A1M Pharma AB
Former ticker
A1M
Market
Nasdaq First North Sweden
Subscription period
06 Feb - 20 Feb 2019
Subscription price
10.20 SEK
Price per share
0.85 SEK
Target to raise
70 539 000 SEK
Types
Share issue
Pre-money valuation
17 500 000 SEK
Subscription block size
Minimum subscription
Record date
31 Jan 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:1. Each existing share entitles one (1) unit right. Three (3) unit rights give the right to subscribe for one (1) unit. One (1) unit contains twelve (12) new shares and four (4) free warrants.
Comments for offer & related information
The rights issue is secured through subscription and guarantee commitments up to 100.0 percent of the total issue amount. The space between 56.0 percent up to 100.0 percent, corresponding to SEK 31.0 million of the Rights Issue consists of a so-called top guarantee with, among others, M2 Asset Management AB and John Fällström.
At the same time, A1M Pharma has raised a bridge loan of SEK 13.0 million. The bridge loan secures A1M Pharma's short-term financing, pending issuance of cash proceeds.
One (1) warrants entitle to subscribe for one (1) new share in the Company at a subscription price of SEK 1.00 during October 2019
Type
Price
Pre-money valuation
Time
Files
New issue
1.05 SEK
108.92M SEK
17 Jun 2019
Share issue in Guard Therapeutics International AB
Former ticker
A1M
Market
Nasdaq First North Sweden
Subscription date
17 Jun 2019
Subscription price
1.05 SEK
Price per share
1.05 SEK
Target to raise
27 230 226 SEK
Types
Share issue
Pre-money valuation
108 920 906 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed issue, subscribers comprise a number of Swedish institutional and private investors consisting of Jan Ståhlberg (SEK 10 million), M2 Asset Management (SEK 7.3 million), the Union (SEK 4.2 million), Axel Karlsson (SEK 2.6 million) , Galba Holding (SEK 2.0 million) and Tommy Ure (SEK 1.1 million).
Comments for offer & related information
The targeted share issue comprises 25,933,549 new shares.

Type
Ticker
ISIN
Market
OPTION
A1M TO 1
SE0006887790
Nasdaq First North Sweden
Sweden (SE)
Details of option in Guard Therapeutics International AB with ticker A1M TO 1
Status
Archived
Order book id
109099
Amount of instruments
Market cap
Currency
SEK
Trading period
09 Jun 2015 - 24 Nov 2015
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
05 Nov - 24 Nov 2015
Option exercise terms for A1M TO 1
Former company name
A1M Pharma AB
Market
Spotlight
Exercise period(s)
05 Nov - 24 Nov 2015
Exercise price
6.00 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share.
Type
Ticker
ISIN
Market
OPTION
A1M TO 2
SE0009773450
Nasdaq First North Sweden
Sweden (SE)
Details of option in Guard Therapeutics International AB with ticker A1M TO 2
Status
Archived
Order book id
137176
Amount of instruments
35 555 556
Market cap
Currency
SEK
Segment
First North
Trading period
20 Jun 2017 - 06 Dec 2017
Terms
Twenty (20) equity rights give the right to subcribe for one (1) new share in A1M Pharma AB.
Type
Price
Pre-money valuation
Time
Files
Exercise
15.00 SEK
28 Aug - 08 Sep 2017
27 Nov - 08 Dec 2017
Option exercise terms for A1M TO 2
Former company name
A1M Pharma AB
Former ticker
A1M TO
Market
Nasdaq First North Sweden
Exercise period(s)
28 Aug - 08 Sep 2017
27 Nov - 08 Dec 2017
Exercise price
15.00 SEK
Status
Closed
Issue terms
Twenty (20) equity rights give the right to subcribe for one (1) new share in A1M Pharma AB.
Type
Ticker
ISIN
Market
OPTION
A1M TO 3
SE0012230696
Nasdaq First North Sweden
Sweden (SE)
Details of option in Guard Therapeutics International AB with ticker A1M TO 3
Status
Archived
Order book id
46AT11
Amount of instruments
27 662 452
Market cap
Currency
SEK
Segment
First North
Trading period
04 Sep 2019 - 23 Oct 2019
Terms
One (1) warrant entitle to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
07 Oct - 25 Oct 2019
Option exercise terms for A1M TO 3
Former company name
A1M Pharma AB
Former ticker
A1M TO
Market
Nasdaq First North Sweden
Exercise period(s)
07 Oct - 25 Oct 2019
Exercise price
1.00 SEK
Status
Closed
Issue terms
One (1) warrant entitle to subscribe for one (1) new share.
People
Number of Employees
5 people
Tobias Agervald
CEO
Cristina Glad
Chairman of the board
Göran Forsberg
Board member
Johannes Hulthe
Board member
Lars Höckenström
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY

Address
Scheelevägen 22
Zip code
223 63
City/district
Lund
Country
Sweden (SE)
Registration number
556755-3226
LEI code
549300DTX7T87FGYG180
First trade date
03 Apr 2013
Company former names
A1M Pharma AB
29 Oct 2019
Registration date
10 Apr 2008
Short name
Guard Therapeutics

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date